| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6803043 |
Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
Oct. 12, 2004 |
| 6803449 |
Nef-attachable protein |
Oct. 12, 2004 |
| 6800286 |
Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof |
Oct. 5, 2004 |
| 6800287 |
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
Oct. 5, 2004 |
| 6800727 |
Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof |
Oct. 5, 2004 |
| 6800730 |
Isolated peptides which bind to MHC class II molecules, and uses thereof |
Oct. 5, 2004 |
| 6800735 |
Interferon-beta fusion proteins and uses |
Oct. 5, 2004 |
| 6797270 |
Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
Sep. 28, 2004 |
| 6797271 |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
Sep. 28, 2004 |
| 6797272 |
Enhanced immunogenicity using leukotoxin chimeras |
Sep. 28, 2004 |
| 6797273 |
Neisseria meningitidis antigen |
Sep. 28, 2004 |
| 6797274 |
Compounds |
Sep. 28, 2004 |
| 6797806 |
Fragments of CR1 and their use |
Sep. 28, 2004 |
| 6797807 |
Compounds and methods for cancer therapy |
Sep. 28, 2004 |
| 6790446 |
Campylobacter vaccine |
Sep. 14, 2004 |
| 6790447 |
Peptides for treatment of autoimmune diseases |
Sep. 14, 2004 |
| 6790448 |
Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them |
Sep. 14, 2004 |
| 6790630 |
DNA and protein from Dirofilaria immitis |
Sep. 14, 2004 |
| 6790631 |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
Sep. 14, 2004 |
| 6787138 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787139 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787140 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787141 |
Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
Sep. 7, 2004 |
| 6787142 |
Mutant human hepatitis B viral strain and uses thereof |
Sep. 7, 2004 |
| 6787143 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787144 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787320 |
In vitro methods for determining in vivo thrombotic events |
Sep. 7, 2004 |
| 6787521 |
Method of inhibiting fibrosis with a somatostatin agonist |
Sep. 7, 2004 |
| 6787523 |
Prevention and treatment of amyloidogenic disease |
Sep. 7, 2004 |
| 6787634 |
Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R). |
Sep. 7, 2004 |
| 6783761 |
Chimeric peptide immunogens |
Aug. 31, 2004 |
| 6780407 |
Pox virus comprising DNA sequences encoding CEA and B7 antigen |
Aug. 24, 2004 |
| 6780416 |
Bee venom polypeptides and methods of use thereof |
Aug. 24, 2004 |
| 6780419 |
Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis |
Aug. 24, 2004 |
| 6780845 |
Compounds and methods for cancer therapy |
Aug. 24, 2004 |
| 6776993 |
Tuberculosis vaccine |
Aug. 17, 2004 |
| 6777540 |
Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand |
Aug. 17, 2004 |
| 6773702 |
Use of combretastatin A4 and its prodrugs as an immune enhancing therapy |
Aug. 10, 2004 |
| 6773706 |
Identification of sortase gene |
Aug. 10, 2004 |
| 6773712 |
Parasitic helminth cuticlin proteins and uses thereof |
Aug. 10, 2004 |
| 6774106 |
Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
Aug. 10, 2004 |
| 6774220 |
Compounds having lectinic properties and their biological applications |
Aug. 10, 2004 |
| 6770284 |
Polypeptides and polynucleotides BASB040 from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
Aug. 3, 2004 |
| 6770460 |
Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus |
Aug. 3, 2004 |
| 6767536 |
Recombinant Staphylococcus thioredoxin reductase and inhibitors thereof useful as antimicrobial agents |
Jul. 27, 2004 |
| 6767545 |
Pseudomonas treatment composition and method |
Jul. 27, 2004 |
| 6764680 |
Combined approach to treatment of cancer with hCG vaccines |
Jul. 20, 2004 |
| 6764681 |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
Jul. 20, 2004 |
| 6764686 |
Modified immunogenic pneumolysin compositions as vaccines |
Jul. 20, 2004 |
| 6761890 |
Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vacci |
Jul. 13, 2004 |
|
|
|
